FDA approves first generic version of Viagra

WASHINGTON — The Food and Drug Administration has given final approval to Teva Pharmaceutical Industries Ltd.’s application to sell a generic version of Pfizer Inc.’s Viagra, the first generic Viagra approved in the U.S.

Israel-based Teva will begin selling the generic Viagra in December 2017.

The FDA has also granted Teva 180-day exclusivity for sales of generic Viagra.

Teva will sell three different strengths of the erectile dysfunction drug: 25 mg, 50 mp and 100 mg, just as Pfizer currently does.

Viagra, whose generic name is sildenafil citrate, generated $1.7 billion in revenue for Pfizer in 2015.

Teva, the world’s largest maker of generic drugs, had $19.7 billion in revenue last year.

Jeff Clabaugh

Jeff Clabaugh has spent 20 years covering the Washington region's economy and financial markets for WTOP as part of a partnership with the Washington Business Journal, and officially joined the WTOP newsroom staff in January 2016.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up